← Ишга қайтиш
Ушбу иш иқтибос қилган ишлар
72 та иш
Иш: Neurological complications after covid-19 vaccination
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin +26
Мақола20208 иқтибосABIEfficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults
Lianpan Dai, Lidong Gao, Lifeng Tao +27
Мақола20227 иқтибосABIEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink +34
Мақола20206 иқтибосABINervous system involvement after infection with COVID-19 and other coronaviruses
Yeshun Wu, Xiaolin Xu, Zijun Chen +5
Шарҳ мақола20205 иқтибосABISafety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Jerald Sadoff, Glenda Gray, An Vandebosch +27
Мақола20214 иқтибосABIAn mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael +30
Мақола20203 иқтибосABISafety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh, Robert W. Frenck, Ann R. Falsey +22
Мақола20203 иқтибосABISafety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Tom T. Shimabukuro, Michael Nguyen, David Martin +1
Шарҳ мақола20153 иқтибосABIThe spectrum of post-vaccination inflammatory CNS demyelinating syndromes
Dimitrios Karussis, Panayiota Petrou
Шарҳ мақола20133 иқтибосABIImprovements in Gene Therapy
Thomas Ritter, Manfred Lehmann, Hans‐Dieter Volk
Шарҳ мақола20022 иқтибосABIIntravascular adenoviral agents in cancer patients: Lessons from clinical trials
Tony Reid, Robert S. Warren, David H. Kirn
Шарҳ мақола20022 иқтибосABIThe influence of innate and pre‐existing immunity on adenovirus therapy
Anne K. Zaiss, Hidevaldo B. Machado, Harvey R. Herschman
Шарҳ мақола20092 иқтибосABIEpilepsy and vaccinations: Italian guidelines
Dario Pruna, Paolo Balestri, Nelia Zamponi +8
Шарҳ мақола20132 иқтибосABIHemostasis factors and aging
Daniela Mari, Raffaella Coppola, Rita Provenzano
Шарҳ мақола20072 иқтибосABI